Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1452864

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1452864

Global Preterm Birth Diagnostic Test Kits Market Size, Share, Growth Analysis, By Test(Biochemical tests, ultrasound), By End-user(Hospitals, clinics) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Preterm Birth Diagnostic Test Kits Market size was valued at USD 446.78 million in 2022 and is poised to grow from USD 479.84 million in 2023 to USD 849.44 million by 2031, growing at a CAGR of 7.4% during the forecast period (2024-2031).

The Global Market for Preterm Birth Diagnostic Test Kits is being propelled by the escalating incidence of preterm births and the imperative for early identification. These kits facilitate prompt and effective evaluation of potential preterm births through the scrutiny of biomarkers and clinical indicators. The market is witnessing expansion driven by heightened awareness among healthcare professionals and expectant mothers, along with advancements in diagnostic technologies. North America and Europe command substantial market shares owing to their robust healthcare infrastructure. Conversely, Asia-Pacific exhibits promising growth due to increasing healthcare expenditure and awareness. Ongoing research and innovation in test kit development are further bolstering market prospects with the aim of alleviating the global burden of preterm births. An emerging trend in the market is the growing emphasis on point-of-care testing, allowing for swift assessments of preterm birth risk in proximity to the patient, which could prove crucial in regions with limited access to advanced healthcare facilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Preterm Birth Diagnostic Test Kits Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Preterm Birth Diagnostic Test Kits Market Segmental Analysis

The global market for preterm birth diagnostic test kits is segmented based on various factors such as test type, end-user, and region. Test types include biochemical tests, ultrasound, genetic screening, and fetal fibronectin tests. End-users comprise hospitals, clinics, diagnostic centers, and research institutions. Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Drivers of the Global Preterm Birth Diagnostic Test Kits Market

Preterm birth, occurring prior to 37 weeks of pregnancy, stands as a prominent global health issue, prompting a growing need for precise and dependable diagnostic test kits to detect and forecast preterm labor. This demand is expected to endure, propelled by the escalating rates of preterm births, while healthcare providers and governments emphasize initiatives to decrease such occurrences and enhance maternal and neonatal health outcomes.

Restraints in the Global Preterm Birth Diagnostic Test Kits Market

The medical diagnostic sector operates under stringent regulations to guarantee patient safety and the effectiveness of products. The process of creating and introducing novel diagnostic test kits, particularly those associated with pregnancy and neonatal care, involves thorough testing and approval procedures. The presence of regulatory obstacles can prolong the release of new test kits, affecting their accessibility and widespread adoption in the market.

Market Trends of the Global Preterm Birth Diagnostic Test Kits Market

The market for diagnostic kits aimed at detecting preterm birth is expected to have progressed due to advancements in diagnostic technologies. These improvements likely encompass the creation of more precise and dependable tests, aiding healthcare professionals in predicting the risk of preterm birth with increased accuracy. The enhancements may involve incorporating a variety of biomarkers, genetic testing, proteomics, and other innovative strategies to elevate the sensitivity and specificity of diagnostic tests.

Product Code: SQMIG35A2560

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Preterm Birth Diagnostic Test Kits Market by Test

  • Market Overview
  • Biochemical tests
  • ultrasound
  • genetic screening
  • and fetal fibronectin tests

Global Preterm Birth Diagnostic Test Kits Market by End-user

  • Market Overview
  • Hospitals
  • clinics
  • diagnostic centers
  • and research institutions

Global Preterm Birth Diagnostic Test Kits Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BD (Becton, Dickinson and Company) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • bioMerieux (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cepheid (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Illumina, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GenMark Diagnostics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Luminex Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories (United Kingdom)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NanoString Technologies (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Myriad Genetics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!